Axon raises growth outlook as AI and counter-drone demand accelerate

Transcript intelligence

What changed

Compared with the prior quarter, revenue-growth guidance moved from 30–32% to 32–34%, while adjusted EBITDA margin guidance stayed around 25.5%. The Q2 analysis also highlighted stronger international bookings, quarterly Dedrone revenue above $100 million, and continued rapid AI expansion.

Guidance delta

Management raised full-year revenue-growth guidance to 32–34%; adjusted EBITDA margin guidance remained approximately 25.5%.

Key takeaways

• Q2 revenue reached $904 million, up 35% year over year, while ARR was $1.6 billion and net revenue retention was 126%.
• Management said AI Era Plan growth was approximately 700% year over year and quarterly Dedrone revenue exceeded $100 million.
• International bookings were roughly three times prior-year levels, with strong TASER demand and continued body-camera replacement activity.
• The next phase depends on scaling AI and counter-drone products while managing privacy, component-cost, and supply-chain risks.

Management priorities

• Scale the AI Era Plan and real-time translation internationally.
• Expand Dedrone and counter-drone offerings through partnerships and broader deployments.
• Continue Axon 911 platform expansion, including Prepared and Carbyne integration.
• Strengthen AI data-access monitoring and privacy safeguards.
• Support international sales and the body-camera and TASER replacement cycles.